Related references
Note: Only part of the references are listed.Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation
Cyrille Touzeau et al.
HAEMATOLOGICA (2017)
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer
Delphine Merino et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation
Cyrille Touzeau et al.
HAEMATOLOGICA (2017)
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
Shaji Kumar et al.
BLOOD (2017)
BH3 profiling identifies heterogeneous dependency on Bcl-2 family members in multiple myeloma and predicts sensitivity to BH3 mimetics
C. Touzeau et al.
LEUKEMIA (2016)
Hierarchy for targeting prosurvival BCL2 family proteins in multiple myeloma: pivotal role of MCL1
Jia-Nan Gong et al.
BLOOD (2016)
Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
Elizabeth A. Punnoose et al.
MOLECULAR CANCER THERAPEUTICS (2016)
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Andras Kotschy et al.
NATURE (2016)
MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor
Yu Xiao et al.
MOLECULAR CANCER THERAPEUTICS (2015)
An interconnected hierarchical model of cell death regulation by the BCL-2 family
Hui-Chen Chen et al.
NATURE CELL BIOLOGY (2015)
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
Joel D. Leverson et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
J. D. Leverson et al.
CELL DEATH & DISEASE (2015)
NbClust: AnRPackage for Determining the Relevant Number of Clusters in a Data Set
Malika Charrad et al.
Journal of Statistical Software (2015)
Designed BH3 Peptides with High Affinity and Specificity for Targeting Mcl-1 in Cells
Glenna Wink Foight et al.
ACS CHEMICAL BIOLOGY (2014)
The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma
C. Touzeau et al.
LEUKEMIA (2014)
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
E. M. Ocio et al.
LEUKEMIA (2014)
Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure
Robert L. Thomas et al.
GENES & DEVELOPMENT (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Delving deeper: MCL-1's contributions to normal and cancer biology
Rhonda M. Perciavalle et al.
TRENDS IN CELL BIOLOGY (2013)
Bcl-xL-inhibitory BH3 mimetics (ABT-737 or ABT-263) and the modulation of cytosolic calcium flux and platelet function
Simone M. Schoenwaelder et al.
BLOOD (2012)
Cell Death via DR5, but not DR4, Is Regulated by p53 in Myeloma Cells
Sylvanie Surget et al.
CANCER RESEARCH (2012)
Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration
Rhonda M. Perciavalle et al.
NATURE CELL BIOLOGY (2012)
Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells
Alejo A. Morales et al.
BLOOD (2011)
The prognostic significance of cytogenetics and molecular profiling in multiple myeloma
Jeffrey R. Sawyer
CANCER GENETICS (2011)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities
Roland Hjerpe et al.
EMBO REPORTS (2009)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex
P Gomez-Bougie et al.
ONCOGENE (2005)
BH3 domains of BH3-only proteins differentially regulate bax-mediated mitochondrial membrane permeabilization both directly and indirectly
T Kuwana et al.
MOLECULAR CELL (2005)
Share Paper
